Authors:
SEGARRA V
CRESPO MI
PUJOL F
BELETA J
DOMENECH T
MIRALPEIX M
PALACIOS JM
CASTRO A
MARTINEZ A
Citation: V. Segarra et al., PHOSPHODIESTERASE INHIBITORY PROPERTIES OF LOSARTAN - DESIGN AND SYNTHESIS OF NEW LEAD COMPOUNDS, Bioorganic & medicinal chemistry letters, 8(5), 1998, pp. 505-510
Authors:
DALPIAZ V
GIOVANNONI MP
CASTELLANA C
PALACIOS JM
BELETA J
DOMENECH T
SEGARRA V
Citation: V. Dalpiaz et al., HETEROCYCLIC-FUSED 3(2H)-PYRIDAZINONES AS POTENT AND SELECTIVE PDE-IVINHIBITORS - FURTHER STRUCTURE-ACTIVITY-RELATIONSHIPS AND MOLECULAR MODELING STUDIES, European journal of medicinal chemistry, 33(10), 1998, pp. 789-797
Authors:
CRESPO MI
PAGES L
VEGA A
SEGARRA V
LOPEZ M
DOMENECH T
MIRALPEIX M
BELETA J
RYDER H
PALACIOS JM
Citation: Mi. Crespo et al., DESIGN, SYNTHESIS, AND BIOLOGICAL-ACTIVITIES OF NEW THIENO[3,2-D]PYRIMIDINES AS SELECTIVE TYPE-4 PHOSPHODIESTERASE INHIBITORS, Journal of medicinal chemistry, 41(21), 1998, pp. 4021-4035
Authors:
COLLADO MC
BELETA J
MARTINEZ E
MIRALPEIX M
DOMENECH T
PALACIOS JM
HERNANDEZ J
Citation: Mc. Collado et al., FUNCTIONAL AND BIOCHEMICAL-EVIDENCE FOR DIAZEPAM AS A CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE TYPE-4 INHIBITOR, British Journal of Pharmacology, 123(6), 1998, pp. 1047-1054
Citation: T. Domenech et al., CHARACTERIZATION OF HUMAN SEROTONIN IN AND 1B RECEPTORS USING [H-3] GR-125743, A NOVEL RADIOLABELED SEROTONIN 5HT1D 1B RECEPTOR ANTAGONIST/, Naunyn-Schmiedeberg's archives of pharmacology, 356(3), 1997, pp. 328-334
Authors:
DALPIAZ V
GIOVANNONI MP
CASTELLANA C
PALACIOS JM
BELETA J
DOMENECH T
SEGARRA V
Citation: V. Dalpiaz et al., NOVEL HETEROCYCLIC-FUSED PYRIDAZINONES AS POTENT AND SELECTIVE PHOSPHODIESTERASE-IV INHIBITORS, Journal of medicinal chemistry, 40(10), 1997, pp. 1417-1421
Authors:
CORTIJO J
MARTICABRERA M
BERNABEU E
DOMENECH T
BOU J
FERNANDEZ AG
BELETA J
PALACIOS JM
MORCILLO EJ
Citation: J. Cortijo et al., CHARACTERIZATION OF 5-HT RECEPTORS ON HUMAN PULMONARY-ARTERY AND VEIN- FUNCTIONAL AND BINDING-STUDIES, British Journal of Pharmacology, 122(7), 1997, pp. 1455-1463
Citation: Lf. Santamaria et al., INHIBITION OF EOTAXIN-MEDIATED HUMAN EOSINOPHIL ACTIVATION AND MIGRATION BY THE SELECTIVE CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE TYPE-4 INHIBITOR ROLIPRAM, British Journal of Pharmacology, 121(6), 1997, pp. 1150-1154
Authors:
MIRALPEIX M
CAMACHO M
LOPEZBELMONTE J
CANALIAS F
BELETA J
PALACIOS JM
VILA L
Citation: M. Miralpeix et al., SELECTIVE INDUCTION OF CYCLO-OXYGENASE-2 ACTIVITY IN THE PERMANENT HUMAN ENDOTHELIAL-CELL LINE HUV-EC-C - BIOCHEMICAL AND PHARMACOLOGICAL CHARACTERIZATION, British Journal of Pharmacology, 121(2), 1997, pp. 171-180
Citation: Jm. Palacios et al., 2ND MESSENGER SYSTEMS AS TARGETS FOR NEW THERAPEUTIC AGENTS - FOCUS ON SELECTIVE PHOSPHODIESTERASE INHIBITORS, Il Farmaco, 50(12), 1995, pp. 819-827
Authors:
DOMENECH T
BELETA J
FERNANDEZ AG
GRISTWOOD RW
SANCHEZ FC
TOLOSA E
PALACIOS JM
Citation: T. Domenech et al., IDENTIFICATION AND CHARACTERIZATION OF SEROTONIN 5-HT4, RECEPTOR-BINDING SITES IN HUMAN BRAIN - COMPARISON WITH OTHER MAMMALIAN-SPECIES, Molecular brain research, 21(1-2), 1994, pp. 176-180